ArticleNature cancer2026
SlideChat is a multimodal generative artificial intelligence assistant for whole-slide computational pathology across cancer types.
Article in Nature cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multimodal artificial intelligence, albeit showing great potential in computational pathology, remains limited to isolated patch-level interpretation and often fails to analyze gigapixel-scale whole-slide images (WSIs) essential for clinical utility. Here we present SlideChat, a multimodal generative artificial intelligence assistant for whole-slide computational pathology across cancer types. SlideChat integrates patch-level and slide-level pathology encoders with a pretrained large language model. Using 274,233 multimodal instruction samples, SlideChat is trained to learn the associations between WSIs and diagnostic reports and interpret complex queries in clinical practice. Evaluated on 8,836 closed-ended questions, 129 open-ended questions and 3,149 WSI reports from five cohorts spanning 31 cancer types, SlideChat outperformed leading baselines by 19.1% in closed-ended accuracy and by 7.7% in report-generation Metric for Evaluation of Translation with Explicit Ordering score and received the highest expert ratings across five dimensions in open-ended question answering, showing the potential to enhance diagnostic workflows, medical education and clinical decision-making.
Indexed as
Identifiers
42680939What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.